放射性药物市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00003751
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 220
Buy Now

放射性药物市场预计将从 2021 年的 75.5074 亿美元增至 2028 年的 138.1817 亿美元;预计 2021 年至 2028 年复合年增长率为 9.0%。

市场的增长归因于慢性病患病率的上升、α 放射免疫疗法在靶向治疗中的适用性癌症治疗和核成像技术的进步。然而,放射性药物的保质期短和替代品的可用性限制了放射性药物市场的增长。放射性药物是一种可用于诊断或治疗目的的药物。放射性药物是与生物分子结合的放射性同位素,针对人体内的特定组织、器官或细胞。发射伽马射线的放射性同位素可用于放射线逸出身体的诊断成像。这些射线由特定设备检测到,该设备通常是单光子发射计算机断层扫描 (SPECT)/正电子发射断层扫描 (PET) 相机。

COVID-19 大流行深刻地改变了医院活动,包括核能欧洲各地的医学 (NM) 实践。对 PubMed 进行了文献检索,涵盖截至 2021 年 1 月发表的 COVID-19 研究。研究结果显示,这一流行病对 NM 部门构成了巨大挑战,欧洲每个中心都经历了劳动力减少。为了限制 COVID-19 的传播,新墨西哥州各部门采取了限制措施,例如重新安排非高优先级程序。此外,由于大流行,一些部门的放射性药物供应或技术援助出现了延误。结果,这场危机导致诊断和治疗 NM 程序大幅减少,以及对受癌症或急性心血管疾病等疾病影响的患者的护理水平降低。

放射性药物市场的利润丰厚的区域< br>

市场洞察

慢性病患病率上升推动放射性药物市场增长

心血管疾病(CVD)、癌症、慢性肺病、中风、阿尔茨海默病、慢性肾病和多种神经系统疾病在世界范围内迅速增加。这些疾病是导致死亡的主要原因之一。根据世界卫生组织 (WHO) 的数据,2020 年全球有 1000 万人死于癌症。此外,根据美国癌症协会的估计,2020年美国新诊断出1,806,590例癌症病例。根据欧洲心脏网络的数据,心血管疾病导致欧洲390万人死亡,欧盟超过180万人死亡(欧盟)每年。他们占欧洲总死亡率的 45.0%,占欧盟总死亡人数的 37.0%。根据美国心脏病学会的数据,心血管疾病每年在美国导致 80 万例死亡。冠心病 (CHD) 是 CVD 死亡的主要原因,其次是中风和心力衰竭;每年有 9000 万美国人被诊断患有心血管疾病。此外,CVD 占全球总死亡人数的 31%,到 2030 年,CVD 给医疗保健系统造成的成本负担预计将达到 10,440 亿美元。

根据 Emory Healthcare 的数据,2018 年,CVD 造成的成本负担将达到 500 万美元。在美国,人们患有充血性心力衰竭(CHF)。此外,根据世界卫生组织的数据,世界上约有 17.1 亿人患有肌肉骨骼疾病。慢性病的治疗必须进行有效的检查,核物质用于诊断和检查;它们用于诊断测试,例如正电子发射断层扫描(PET)和单光子发射计算机断层扫描(SPECT)。因此,随着慢性病发病率的激增,对放射性药物的需求也在增加,从而推动了市场的增长。

基于类型的见解

基于类型,放射性药物市场分为诊断核医学和治疗核医学。诊断核医学领域占据着更大的市场份额,预计 2021 年至 2028 年复合年增长率将更高。广泛用于诊断核医学的放射性同位素是锝-99m。放射性同位素附着在几种特定分子上,可以诊断各种疾病,例如某些类型的癌症。例如,technetium-99m-MDP(亚甲基二磷酸盐)被广泛用于检测与癌症相关的骨转移。

放射性药物市场,按类型划分 – 2021 年和 2028 年

基于产品类型的见解

根据产品类型,放射性药物市场分为 Technetium-99m、Thallium-201、Gallium-67 、碘-131、铜-64 等。 Technetium-99m 细分市场占据最大的市场份额,而镓-67 细分市场预计在 2021 年至 2028 年期间复合年增长率最高。 Gallium-67 用于炎症病变(感染)的成像和定位。 Gallium-67 是一种注射放射性药物,与单光子发射计算机断层扫描 (SPECT) 结合使用,可检测急性炎症病变和各种恶性肿瘤的存在,例如霍奇金病、淋巴瘤和支气管癌。

基于应用的见解

根据应用,放射性药物市场分为肿瘤学、心脏病学、神经学等。肿瘤学领域占据最大的市场份额。该领域的市场增长可归因于全球癌症发病率的增加。癌症是死亡率很高的重大健康问题之一。这是对全球健康的威胁。据世界卫生组织统计,2018年,全球估计新诊断出1800万癌症病例,960万人死于癌症。然而,心脏病学领域的市场预计在未来几年将以最快的速度增长。

基于最终用户的见解

基于最终用户,放射性药物市场分为医院、成像中心、学术和研究中心等。 2021年,医院领域将占据最大的市场份额。该领域的市场增长可归因于慢性病患病率的上升、世界各地医院数量的增加以及外科手术数量的迅速增长。然而,诊断中心领域的市场预计在未来几年将以最快的速度增长。


战略见解

在放射性药物市场运营的公司正在采用产品创新战略,以满足世界各地不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌。

放射性药物市场 -按类型

  • 诊断核医学
    • SPECT放射性药物
    • PET放射性药物
  • 治疗性核医学医学
    • α发射体
    • β发射体
    • 近距离放射治疗同位素

放射性药物市场按产品类型

  • Technetium-99m
  • 铊-201
  • 镓-67
  • 碘-131
  • Copper-64
  • 其他

放射性药物市场 -按应用划分

  • 肿瘤学
  • 心脏病学
  • 神经学
  • 其他

放射性药物市场–按最终用户划分

  • 医院
  • 影像中心
  • 学术和研究中心
  • 其他

放射性药物市场–按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • MEA其他地区
  • 南美洲和中美洲(SCAM )
    • 巴西
    • 阿根廷
    • 其他骗局

公司简介

  • 康德乐
  • GE Healthcare
  • Curium
  • Lantheus Medical Imaging
  • 拜耳股份公司
  • < li>Bracco Imaging
  • Eczacàbaþà-Monrol 核产品
  • Nordion
  • 先进加速器应用
  • NTP 放射性同位素
  • Nordion
  • 高级加速器应用
  • NTP 放射性同位素
  • Nordion
  • 高级加速器应用
  • NTP 放射性同位素
  • Nordion
  • 高级加速器应用li>
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are radiopharmaceuticals?

Radiopharmaceuticals are radioisotopes that are bound to biological molecules that target specific tissues, organs, or cells within the human body. Radioisotopes emitting gamma rays are useful for diagnostic imaging where the radiation escapes the body. These rays are detected by a specific device, which is usually single-photon emission computed tomography (SPECT)/ positron emission tomography (PET) cameras.

What are the driving factors for the radiopharmaceuticals market across the globe?

The factors that are driving growth of the market are rising prevalence of chronic diseases, suitability of alpha radioimmunotherapy in targeted cancer treatment, and advancements in nuclear imaging techniques.

Who are the developments carrying out by major players in the radiopharmaceuticals market?

Various companies have made organic growth strategies in the Radiopharmaceuticals Market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Lantheus Medical Imaging, Inc., Bracco Imaging S.p.A, Advanced Accelerator Applications amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

Which region is dominated the radiopharmaceuticals market?

North America dominates the global radiopharmaceuticals market due to factors such as technological advancement, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.

Which segment is growing at the highest CAGR in the radiopharmaceuticals market?

The diagnostic nuclear medicine segment is growing at the highest CAGR owing to availability of diagnostic devices and ease offered by these devices for diagnosis of various disorders. Also, nuclear medicine provides better diagnostic information about the functioning of a specific organ, as it uses radiation.

Which region is the fastest growing in the radiopharmaceuticals market?

Asia Pacific is expected to be the fastest growing region in the radiopharmaceuticals market. The growth of the market in this region is primarily due to prevalence of stroke and other neurological disorders along with the presence of supportive government initiatives and research in the field of radiopharmaceuticals.

The List of Companies - Radiopharmaceuticals Market

  1. Cardinal Health
  2. GE Healthcare
  3. Curium
  4. Lantheus Medical Imaging
  5. Bayer AG
  6. Bracco Imaging
  7. Eczacýbaþý-Monrol Nuclear Products
  8. Nordion
  9. Advanced Accelerator Applications
  10. NTP Radioisotopes

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports